Cullinan Therapeutics stock opened at $8.71 on Friday. Cullinan Therapeutics has a 1 year low of $7.90 and a 1 year high of $30.19. The firm has a 50 day moving average price of $10.14 and a 200 ...

The General Confederation of Moroccan Enterprises (CGEM) urged the government Monday to continue its reforms aimed at boosting private investment, particularly in small and medium enterprises (SMEs).

Morgan Stanley assumed coverage of Cullinan Therapeutics (CGEM) with an Overweight rating and a price target of $35, down from $38. The firm ...

Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been given a consensus rating of “Buy” by the eight research firms that are covering the firm, MarketBeat.com reports.

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Cullinan Therapeutics, Inc. (CGEM) on Thursday reported a loss of $47.6 million in its fourth quarter. The Cambridge, Massachusetts-based company said ...

Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on Cullinan Management (CGEM – Research Report) today and set a price target of $30.00. The company’s shares closed yesterday at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stay updated on market trends for CGEM. MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures were lower this morning ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...